Legis Daily

National Commission on the COVID–19 Pandemic in the United States Act

USA116th CongressS-4132| Senate 
| Updated: 7/1/2020
Dianne Feinstein

Dianne Feinstein

Democratic Senator

California

Cosponsors (15)
Mazie K. Hirono (Democratic)Edward J. Markey (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Kamala D. Harris (Democratic)Thomas R. Carper (Democratic)Amy Klobuchar (Democratic)Robert P. Casey (Democratic)Chris Van Hollen (Democratic)Tina Smith (Democratic)Tammy Baldwin (Democratic)Benjamin L. Cardin (Democratic)Jeff Merkley (Democratic)Richard Blumenthal (Democratic)

Rules and Administration Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
National Commission on the COVID-19 Pandemic in the United States Act This bill establishes, in the legislative branch, the National Commission on the COVID-19 Pandemic in the United States and sets forth its powers, duties, funding, and membership. Among other activities, the commission shall investigate the facts and circumstances of the COVID-19 (i.e., coronavirus disease 2019) pandemic and make recommendations on preventing a similar outbreak from occurring in the future. The commission terminates 60 days after the submission of its final report.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2020

Latest Companion Bill Action

HR 116-6548
Introduced in House
Jul 1, 2020
Introduced in Senate
Jul 1, 2020
Read twice and referred to the Committee on Rules and Administration. (Sponsor introductory remarks on measure: CR S4138-4139)
  • April 17, 2020

    Latest Companion Bill Action

    HR 116-6548
    Introduced in House


  • July 1, 2020
    Introduced in Senate


  • July 1, 2020
    Read twice and referred to the Committee on Rules and Administration. (Sponsor introductory remarks on measure: CR S4138-4139)

Health

Related Bills

  • HR 116-8358: National Coronavirus Commission Act of 2020
  • S 116-4666: National Coronavirus Commission Act of 2020
  • HR 116-6548: National Commission on the COVID–19 Pandemic in the United States Act
Advisory bodiesBorder security and unlawful immigrationCardiovascular and respiratory healthCongressional operations and organizationCongressional oversightDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careEmergency planning and evacuationGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careImmigration status and proceduresInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationIntergovernmental relationsInternational organizations and cooperationLaw enforcement administration and fundingState and local government operations

National Commission on the COVID–19 Pandemic in the United States Act

USA116th CongressS-4132| Senate 
| Updated: 7/1/2020
National Commission on the COVID-19 Pandemic in the United States Act This bill establishes, in the legislative branch, the National Commission on the COVID-19 Pandemic in the United States and sets forth its powers, duties, funding, and membership. Among other activities, the commission shall investigate the facts and circumstances of the COVID-19 (i.e., coronavirus disease 2019) pandemic and make recommendations on preventing a similar outbreak from occurring in the future. The commission terminates 60 days after the submission of its final report.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2020

Latest Companion Bill Action

HR 116-6548
Introduced in House
Jul 1, 2020
Introduced in Senate
Jul 1, 2020
Read twice and referred to the Committee on Rules and Administration. (Sponsor introductory remarks on measure: CR S4138-4139)
  • April 17, 2020

    Latest Companion Bill Action

    HR 116-6548
    Introduced in House


  • July 1, 2020
    Introduced in Senate


  • July 1, 2020
    Read twice and referred to the Committee on Rules and Administration. (Sponsor introductory remarks on measure: CR S4138-4139)
Dianne Feinstein

Dianne Feinstein

Democratic Senator

California

Cosponsors (15)
Mazie K. Hirono (Democratic)Edward J. Markey (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Kamala D. Harris (Democratic)Thomas R. Carper (Democratic)Amy Klobuchar (Democratic)Robert P. Casey (Democratic)Chris Van Hollen (Democratic)Tina Smith (Democratic)Tammy Baldwin (Democratic)Benjamin L. Cardin (Democratic)Jeff Merkley (Democratic)Richard Blumenthal (Democratic)

Rules and Administration Committee

Health

Related Bills

  • HR 116-8358: National Coronavirus Commission Act of 2020
  • S 116-4666: National Coronavirus Commission Act of 2020
  • HR 116-6548: National Commission on the COVID–19 Pandemic in the United States Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesBorder security and unlawful immigrationCardiovascular and respiratory healthCongressional operations and organizationCongressional oversightDiplomacy, foreign officials, Americans abroadEmergency medical services and trauma careEmergency planning and evacuationGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careImmigration status and proceduresInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationIntergovernmental relationsInternational organizations and cooperationLaw enforcement administration and fundingState and local government operations